secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ultragenyx Pharmaceutical Inc. (RARE)
CIK:        0001515673
Form:       8-K
Filed at:   2023-10-23T23:59:59+00:00
Accession:  0001193125-23-260305
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultragenyx prices $300M public offering of common stock and pre-funded warrants
-------------------------------------------------------------------------------

- 8,333,334 shares at $30.00/share plus 1,666,722 pre-funded warrants at $29.9990 each.
- Underwriters exercised option for 1,500,000 additional shares; total net proceeds ~$326.1M.
- Offering expected to close October 23, 2023.
- J.P. Morgan, Goldman Sachs, BofA Securities, Cowen acted as underwriters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1515673/000119312523260305/0001193125-23-260305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1515673/000119312523260305/d524225d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-260305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer